世界の医薬品卸売及び流通市場:地域別分析、主要企業分析...市場調査レポートについてご紹介

【英文タイトル】PHARMA WHOLESALE AND DISTRIBUTION INDUSTRY AND MARKET: WORLD OUTLOOKS AND FORECASTS 2014-2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 The Global Pharma Wholesale and Distribution Industry and Market Review
1.2 The Global Pharma Wholesale and Distribution Industry Structure
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Main Questions Answered by This Analytical Report
1.6 Who is This Study For?
1.7 Methods of Research and Analysis
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to Pharma Wholesale and Distribution
2.1 The Role of Pharmaceutical Wholesalers: The Middlemen of the Pharmaceutical Industry
2.1.1 Full-Line Wholesalers (FLWs)
2.1.2 Short-Line Wholesalers (SLWs)
2.2 The Chain of Distribution: Wholesalers vs. Logistics Service Providers
2.2.1 Secondary Wholesalers
2.2.2 Direct-to-Pharmacy (DTP) Distribution is Becoming More Prevalent
2.2.3 Major Wholesalers: Distribute a Large Amount of Products to Generate High Profit
2.2.4 Distribution from Large to Small Wholesalers: A Lengthy Distribution Chain
2.2.5 Pharmacy Benefit Managers
2.3 Generating Revenue and Profit
2.3.1 Forward Buying to Avoid Price Increases
2.3.2 Fee-for-Service: A Clearer Pricing Structure
2.3.2.1 Inventory Management Agreements
2.3.3 Discounts: Incentives for Prompt Payment or Bulk Purchases
2.3.4 Reimbursement and Wholesalers
2.3.5 Clawback: The Recovery of Reimbursement Costs by Governments
2.3.6 Parallel Trade: Different Attitudes in Europe and the US

3. The World Pharmaceutical Wholesale and Distribution Market, 2014-2024
3.1 The World Pharmaceutical Wholesale and Distribution Market in 2013, Restricted by Government Price Reductions and Generic Substitution
3.2 The Pharmaceutical Wholesale and Distribution: World Market Forecast, 2014-2024
3.3 Branded and Generic Drugs: Revenue vs. Profit, 2014-2024
3.3.1 Branded and Generic Drugs: Revenue Generation, 2013
3.3.2 Branded Drugs, Generic Drugs and Others: Revenue Forecasts, 2014-2024
3.3.3 Branded Drugs: Revenue Forecast, 2014-2024
3.3.4 Generic Drugs: Revenue Forecast, 2014-2024

4. Pharmaceutical Wholesale and Distribution Industry: Leading National Markets, 2014-2024
4.1 Leading National Markets: The US Dominated in 2013
4.2 Leading National Markets: Revenue The Future of the Leading National Markets: Will the US Continue to Dominate the Market?
4.3 The US Pharma Wholesale and Distribution Market
4.3.1 The Budget Control Act and its Effect on the US Wholesale and Distribution Industry
4.3.2 Legislation to Prevent Counterfeit Drugs Can Differ Between States
4.3.3 An Increase in Fee-For-Service Activity
4.3.4 Pharma Wholesale and Distribution Market in the US: Market Forecast, 2014-2024
4.4 The Leading European (EU5) Pharma Wholesale and Distribution Markets
4.4.1 Differences Between the US and Europe
4.4.2 State-Funded Healthcare and Reimbursement
4.4.3 EU5: Market Forecast, 2014-2024
4.4.4 Germany: Pharma Wholesale and Distribution Market, 2013
4.4.4.1 Healthcare Reform
4.4.4.2 Germany: Reform of AMNOG Pharmaceutical Rebate Law
4.4.4.3 Germany Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.5 France: Pharma Wholesale and Distribution Market, 2013
4.4.5.1 France: Social Security Finance Bill 2014
4.4.5.2 France: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.6 Italy: Pharma Wholesale and Distribution Market, 2013
4.4.6.1 Italy: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.7 Spain: Pharma Wholesale and Distribution Market, 2013
4.4.7.1 Spain: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.4.8 UK: Pharma Wholesale and Distribution Market, 2013
4.4.8.1 Price Cuts in the UK
4.4.8.2 UK: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.5 Japan: Pharma Wholesale and Distribution Market, 2013
4.5.1 Drug Pricing and Performing Fees in Japan
4.5.2 Japan: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.6 China: Pharma Wholesale and Distribution Market, 2013
4.6.1 China: Leading Pharma Wholesale and Distribution Companies, 2013
4.6.2 China: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.7 Brazil: Pharma Wholesale and Distribution Market, 2013
4.7.1 Drug Price Controls in Brazil
4.7.2 Brazil: Leading Pharma Wholesale and Distribution Companies, 2013
4.7.3 Brazil: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.8 India: Pharma Wholesale and Distribution Market, 2013
4.8.1 India: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.9 Russia: Pharma Wholesale and Distribution Market, 2013
4.9.1 Drug Pricing Controls in Russia
4.9.2 Market Trends in Russia
4.9.3 Russia: Pharma Wholesale and Distribution Market Forecast, 2014-2024
4.10 Conclusion

5. Leading Pharma Wholesalers and Distributors in 2014: Current and Future Performance
5.1 The Leading Wholesale and Distribution Companies in 2013
5.2 Revenue vs. Profit
5.3 Leading Pharma Wholesale and Distribution Companies: Grouped Forecasts, 2014-2024
5.4 McKesson: The Oldest and Largest Healthcare Services Company in the US
5.4.1 McKesson: Historical Performance, 2008-2013
5.4.2 Future Strategies: Consummate Acquisitions to Complement Existing Business or Expand Businesses
5.4.3 McKesson: Revenue Forecast, 2014-2024
5.5 Cardinal Health: The World’s Second Largest Pharma Wholesaler
5.5.1 Cardinal Health: Historical Performance, 2008-2013
5.5.2 Will CVS Joint Venture and Acquisitions Stimulate Future Growth?
5.5.3 Cardinal Health: Revenue Forecast, 2014-2024
5.6 AmerisourceBergen: Third Largest Global Pharma Wholesaler and Distributor
5.6.1 AmerisourceBergen: Historical Performance, 2008-2013
5.6.2 Will Contracts with Walgreens and Alliance Boots Drive Future Growth?
5.6.3 AmerisourceBergen: Revenue Forecast 2014-2024
5.7 Alliance Boots: The Largest European Wholesaler
5.7.1 Alliance Boots: Historical Performance, 2008-2013
5.7.2 Future Strategies of Alliance Boots: Merger Plan with Walgreens to Become the Largest Provider of Healthcare Services
5.7.3 Alliance Boots: Revenue Forecast, 2014-2024
5.8 MEDIPAL HOLDINGS CORPORATION: Japan’s Leading Pharmaceutical Wholesaler
5.8.1 MEDIPAL HOLDINGS CORPORATION: Historical Performance, 2008-2013
5.8.2 Future Strategies of MEDIPAL HOLDINGS CORPORATION: Revised Business Portfolio with Diverse Sources of Earnings
5.8.3 MEDIPAL HOLDINGS CORPORATION: Revenue Forecast, 2014-2024
5.9 The PHOENIX Group: Second Biggest Wholesaler in Europe
5.9.1 The PHOENIX Group: Historical Performance, 2008-2013
5.9.2 Future Strategies of the PHOENIX Group: Selective Acquisitions
5.9.3 The PHOENIX Group: Revenue Forecast, 2014-2024
5.10 SINOPHARM: The Leading Pharmaceutical Wholesaler and Distributor in China
5.10.1 SINOPHARM: Historical Performance, 2008-2013
5.10.2 Future Strategies of SINOPHARM: Provide Comprehensive Services and Wider Business Coverage
5.10.3 SINOPHARM: Revenue Forecast, 2014-2024
5.11 Alfresa Holdings: Second Largest Pharmaceutical Wholesaler and Distributor in Japan
5.11.1 Alfresa Holdings: Historical Performance, 2008-2013
5.11.2 Future Strategy of Alfresa Holdings: To Focus on Expanding Business Fields and Increasing Footprint
5.11.3 Alfresa Holdings: Revenue Forecast, 2014-2024
5.12 SUZUKEN CO., LTD: The First Nationwide Wholesaler of Japan
5.12.1 SUZUKEN CO., LTD: Historical Performance, 2008-2013
5.12.2 Future Strategies of SUZUKEN CO., LTD: Five Growth Initiatives and Special Focus on Diabetes Field
5.12.3 SUZUKEN CO., LTD: Revenue Forecast, 2014-2024
5.13 Shanghai Pharmaceuticals Holding: China’s Second Largest Wholesaler
5.13.1 Shanghai Pharmaceuticals Holding: Historical Performance, 2008-2013
5.13.2 Future Strategies of Shanghai Pharma: Expansion of Three Leading Regions in China
5.13.3 Shanghai Pharma: Revenue Forecast, 2014-2024

6. Qualitative Analysis of the Pharma Wholesale and Distribution Market
6.1 Strengths and Weaknesses of the Pharma Wholesale and Distribution Market, 2014
6.1.1 The Insatiable Demand for Drugs: A Recession-Proof Industry?
6.1.2 Wholesalers Do More than Deliver Drugs
6.1.2.1 Pre-Wholesaling: More Prevalent in Europe
6.1.2.2 Through Pre-Financing, Full-Line Wholesalers Finance the Entire Medicines Market
6.1.3 Large Companies Dominate the Market
6.1.4 Despite High Revenues, Profit Margins Are Low
6.1.5 Government-Induced Drug Price Pressures Restrict Profits
6.1.6 The Problem of Counterfeit Drugs
6.2. The Opportunities and Threats of the Pharma Wholesale and Distribution Market, 2014-2024
6.2.1The Demand for Pharmaceuticals is Increasing
6.2.2 The Increasing Use of Specialty Drugs Will Drive Growth
6.2.3 The Increasing Use of Generic Drugs Will Limit Revenue, But Drive Profit Generation
6.2.4 The Promotion of Drug Therapy in the US
6.2.5 Globalisation: The Major National Markets are Dominated by Few Companies
6.2.6 Increased Adoption of the DTP Distribution Model
6.2.6.1 DTP in Europe: The First Place the Scheme Has Taken Hold
6.2.6.2 DTP in the UK Since 1991
6.2.6.3 DTP in Poland: The Second European Country to Adopt the DTP Model
6.2.6.4 Further Expansion of the DTP Model
6.2.7 The Threat of Healthcare Budget Cuts
6.2.7.1 Healthcare Budget Cuts in Germany
6.2.7.2 Healthcare Budget Cuts in France
6.2.7.3 Healthcare Budget Cuts in Italy
6.2.7.4 Healthcare Budget Cuts in Spain
6.2.7.5 Healthcare Budget Cuts in the UK
6.2.8 Do Large Pharmacy Chains Pose a Threat?
6.2.8.1 Case Study: Walmart and the $4.0 Prescription Scheme
6.2.8.2 Vertical Integration of Wholesalers: A Response to the Threat of Pharmacy Chains
6.2.9 Does the Diversion and Re-importation of Medicines Pose a Threat to the Industry?
6.2.10 The Threat of Industry Consolidation
6.3 Social, Technological, Economical and Political Factors Influencing the Market, 2014-2024 (STEP Analysis)
6.3.1 Political Factor: The Impact of Recent Regulatory Changes in the EU
6.3.2 Political Factor: Combating Counterfeit Medicines
6.3.2.1 The US and E-Pedigree: Becoming Law in California
6.3.2.2 European Pedigree Legislation
6.3.2.3 Anti-Counterfeiting Strategies in Other Markets: The Chinese Government is Attempting to Address the Challenge
6.2.3.4 Serialisation for Wholesalers: Opportunity or a Challenge?

7. Research Interviews
7.1 Interview with Mr Chris Frost, Sales Director of AAH Pharmaceuticals Ltd. (Celesio UK), Coventry
7.1.1 Current Status and Evolution of Pharma Wholesale and Distribution Market in the UK
7.1.2 Driving Factors of the Pharma Wholesale and Distribution Market in the UK
7.1.3 Future of the UK Pharma Wholesale and Distribution Market
7.1.4 Celesio UK Accounted for More Than 60% of the Group’s Total Retail Pharmacy Business in 2013
7.1.5 The Outcome of McKesson’s Acquisition of Celesio AG
7.1.6 Prominent Business Segments of Celesio AG in the Future
7.2 Interview with Dr Evelyn Walter, Co-Founder and Director of the Institute for Pharmaeconomic Research (IPF), Vienna
7.2.1 On Direct-to-Pharmacy Distribution
7.2.2 On the Effect of Drug Pricing Pressures on the Supply of Pharmaceuticals
7.2.3 On the Role of Pharmaceutical Wholesalers and Distributors in European Healthcare Systems
7.2.4 On the Impact of Counterfeit Drugs
7.2.5 On the Efficacy of the Pharmaceutical Wholesale and Distribution Industry

8. Conclusions from the Research and Analysis
8.1 The Future of the Pharma Wholesale and Distribution Market
8.2 The Leading National Pharma Wholesale and Distribution Markets
8.3 The Leading Companies in the Pharma Wholesale and Distribution Industry
8.4 Trends in the Pharma Wholesale and Distribution Industry
8.4.1 Generics Will Threaten Revenue
8.4.2 Manufacturers Will Deliver More Drugs Directly
8.4.3 There Will Be Greater Demand for Specialty Medicines
8.4.4 Consolidation Will Drive Growth
8.4.5 Anti-Counterfeiting Demands Will Add to Wholesaler’s Costs


【レポート販売概要】

■ タイトル:世界の医薬品卸売及び流通市場:地域別分析、主要企業分析
■ 英文:PHARMA WHOLESALE AND DISTRIBUTION INDUSTRY AND MARKET: WORLD OUTLOOKS AND FORECASTS 2014-2024
■ 発行日:2014年9月
■ 調査会社:visiongain
■ 商品コード:VISG409042
■ 調査対象地域:グローバル
  • Glycogenの世界市場
    Glycogen (CAS 9005-79-2) Market Research Report 2013 presents comprehensive data on glycogen markets globally and regionally (Europe, Asia, North America etc.) The Glycogen (CAS 9005-79-2) Market Research Report 2013 includes glycogen description, covers its application areas and related patterns. It overviews glycogen market, names glycogen producers and indicates its suppliers. Besides, the Glyc …
  • 悪性線維性組織球腫:グローバル臨床試験レビュー(2014年上半期)
    Malignant Fibrous Histiocytoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Malignant Fibrous Histiocytoma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Fibrous Histiocytoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Fibrous Histiocytoma. It includes an o …
  • 空気絶縁スイッチギアの世界市場2019-2023
    About Air Insulated Switchgear Air insulated switchgear (AIS) is a transmission and distribution componenet, which is primarily used as a circuit controller and breaker. It uses air as a insulating material. Technavio’s analysts forecast the global air insulated switchgear to grow at a CAGR of 7.05% during the period 2019-2023. Covered in this report The report covers the present scenario and the …
  • 陰圧閉鎖療法(NPWT)の世界市場分析および予測
    MediPoint: Negative Pressure Wound Therapy - Global Analysis and Market Forecasts Summary Negative pressure wound therapy (NPWT), sometimes referred to as topical negative pressure therapy or vacuum-assisted wound closure, is an emerging advanced wound management technology that is being utilized in the treatment of both acute and chronic wounds. The treatment entails using a vacuum that exerts ne …
  • 消化酵素サプリメントの世界市場分析:起源別(動物、植物、微生物)、用途別(追加サプリメント、医療・幼児栄養、スポーツ栄養)、地域別(北アメリカ、ヨーロッパ、アジア太平洋、CSA、MEA)、セグメント予測、2014-2025
    The global digestive enzyme supplements market is expected to reach USD 1.6 billion by 2025, according to a new report published by Grand View Research, Inc. Growing consumer awareness regarding the severity of digestive disorders coupled with the need for good health is expected to stimulate industry growth over the forecast period. The increasing incidence of gastrointestinal tract diseases, suc …
  • Neupro (パーキンソン病):医薬品市場予測及び分析(~2022)
    Neupro (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly. Do …
  • Ithaca Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013
    Ithaca Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Ithaca Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
  • Enteric Diseases in Spain 2014: Market Outlook and Emerging Opportunities
    About This ReportThis new 322-page report from Venture Planning Group presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales projections for Hospitals and Commercial/Priv …
  • ユーバイオティクスの世界市場予測(~2022):種類別(プロバイオティクス、プレバイオティクス、有機酸、エッセンシャルオイル)、家畜別、形状別、機能別
    The eubiotics market is projected to grow at a CAGR of 7.51% to reach USD 7.47 Billion by 2022. The market is driven by factors such as increase in awareness about feed quality and safety, rise in demand for manufactured animal feed, growth in demand for animal high protein, change in framing practices and technology, and replacing antibiotic growth promoters (AGPs) with eubiotics. Continuous rise …
  • UCaaS(Unified Communication as a service)の世界市場(2014-2019)
    UCaaS provides integration of UC services such as telephony, unified messaging, conferencing, and collaboration platforms and applications. It provides different solutions which help businesses communicate anywhere in a cost-effective manner. For Small and medium-sized Businesses (SMBs), UCaaS can be very helpful as it helps them in saving their front-load capital and provides a per seat basis ren …
  • ブロックチェーンデバイスの世界市場予測(~2024年)
    Blockchain devices market to grow at CAGR of 42.5% from 2019 to 2024The blockchain devices market is projected to grow from USD 218 million in 2019 to USD 1,285 million by 2024, at a CAGR of 42.5% from 2019 to 2024. Some of the major growth drivers for this market include increasing adoption of blockchain technology in retail & supply chain management, rising venture capital funding, and growing m …
  • 世界のエネルギーセキュリティー市場:Global Energy Security Market 2014-2018
    TechNavio's analysts forecast the Global Energy Security market to grow at a CAGR of 6.5 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased occurrence of cyber threats. The Global Energy Security market has also been witnessing the increase in the construction of smart grid. However, the unpredictability of cyber threats could pose a chall …
  • 皮膚診断デバイスの世界市場
    The global dermatology diagnostic devices market is estimated to grow at a CAGR of 8.2% from 2014 to 2019. North America and Europe hold larger shares in the global dermatology diagnostic devices market. The growth of the global dermatology diagnostic devices market is mainly attributed to a wide range of factors, such as increasing incidence of skin disorders, growing demand of dermatologists, an …
  • 先進超高周波(AEHF)システムの世界市場2016-2020
    About Advanced Extremely High Frequency (AEHF) Systems Advanced extremely high frequency (AEHF) is a series of communications satellite systems operated by the US Air Force Space Command. They are used to relay secure communications for the US Armed Forces, the British Army, the Canadian Armed Forces, and the Royal Netherlands Forces. The AEHF system will replace the older Milstar system with six …
  • 拡張現実市場分析と予測(Augmented Reality: Global Market Analysis and Forecast 2012 – 2017)
    Augmented Reality (AR) is a live, direct or indirect, view of a physical, real-world environment whose elements are augmented by computer-generated sensory input, that enrich the user's perception of the real world. Although AR is often perceived to be in the visual domain (video or graphics etc), it actually includes the other senses as well such as sound or GPS data. The popularity of smartphone …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。